Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-11-002672
Filing Date
2011-11-23
Accepted
2011-11-22 20:32:09
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q elgo_10q.htm 10-Q 640669
2 CERTIFICATION elgo_ex311.htm EX-31.1 11919
3 CERTIFICATION elgo_ex312.htm EX-31.2 12712
4 CERTIFICATION elgo_ex321.htm EX-32.1 6624
5 CERTIFICATION elgo_ex322.htm EX-32.2 6844
  Complete submission text file 0001477932-11-002672.txt   1626490

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT elgo-20110930.xml EX-101.INS 120678
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elgo-20110930.xsd EX-101.SCH 15634
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT elgo-20110930_cal.xml EX-101.CAL 21188
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT elgo-20110930_def.xml EX-101.DEF 17098
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elgo-20110930_lab.xml EX-101.LAB 105601
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elgo-20110930_pre.xml EX-101.PRE 66426
Mailing Address 1264 UNIVERSITY AVENUE WEST SUITE 404 ST. PAUL MN 55104
Business Address 1264 UNIVERSITY AVENUE WEST SUITE 404 ST. PAUL MN 55104 5163038181
Enterologics, Inc. (Filer) CIK: 0001483731 (see all company filings)

EIN.: 800504940 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54347 | Film No.: 111223217
SIC: 2834 Pharmaceutical Preparations